Advancements in Cancer Care: Impact on Insurance Industry Dynamics
Explore how recent advancements in cancer care impact the insurance industry, focusing on CAR T-cell therapy and regulatory compliance.
U.S. Pediatric Uninsured Rates Rise, Impacting Child Cancer Outcomes
In 2024, over four million U.S. children were uninsured, the highest rate in a decade, worsening pediatric cancer diagnosis delays and mortality. Fragmented insurance and Medicaid enrollment gaps drive coverage loss.
CMS Negotiates Discounts on 15 Drugs, Including Cancer Therapies
CMS has secured significant price reductions on 15 drugs including costly cancer treatments, impacting Medicare Part B pricing and healthcare costs.
ASTRO Supports Prior Authorization Reform in Medicare Advantage to Improve Cancer Care
ASTRO backs bipartisan legislation to reform Medicare Advantage prior authorization, aiming to reduce cancer treatment delays and improve care outcomes.
Medicare Caps Oral Cancer Drug Costs and Expands Payment Options in 2025
New Medicare Part D rules in 2025 cap oral cancer drug costs at $2,000 annually and introduce a voluntary monthly payment plan to improve affordability for patients.
Study Finds Medicare Advantage Patients Face Longer, Costlier Radiotherapy Than Traditional Medicare
New Harvard study compares radiotherapy utilization and spending between Medicare Advantage and Traditional Medicare, highlighting longer treatment durations and higher costs for MA patients.
Medicaid Expansion Boosts Quick Access to Quality Lung Cancer Treatment
Recent study links Medicaid expansion under the Affordable Care Act to enhanced lung cancer treatment, with quicker surgeries at high-volume hospitals and better patient outcomes.